Danielle Halpern

4.3k total citations
30 papers, 1.2k citations indexed

About

Danielle Halpern is a scholar working on Genetics, Cognitive Neuroscience and Molecular Biology. According to data from OpenAlex, Danielle Halpern has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 22 papers in Cognitive Neuroscience and 8 papers in Molecular Biology. Recurrent topics in Danielle Halpern's work include Autism Spectrum Disorder Research (22 papers), Genetics and Neurodevelopmental Disorders (19 papers) and Genomic variations and chromosomal abnormalities (9 papers). Danielle Halpern is often cited by papers focused on Autism Spectrum Disorder Research (22 papers), Genetics and Neurodevelopmental Disorders (19 papers) and Genomic variations and chromosomal abnormalities (9 papers). Danielle Halpern collaborates with scholars based in United States, United Kingdom and France. Danielle Halpern's co-authors include A. Ting Wang, Alexander Kolevzon, Joseph D. Buxbaum, William F. Chaplin, Latha Soorya, Yitzchak Frank, Paige M. Siper, David Grodberg, Evdokia Anagnostou and Jennifer A. Bartz and has published in prestigious journals such as PEDIATRICS, Human Molecular Genetics and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Danielle Halpern

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danielle Halpern United States 15 618 617 350 237 173 30 1.2k
A. Ting Wang United States 11 565 0.9× 634 1.0× 293 0.8× 225 0.9× 161 0.9× 14 1.1k
Meixiang Jia China 17 422 0.7× 491 0.8× 264 0.8× 464 2.0× 167 1.0× 36 1.2k
Carolyn M. Yrigollen United States 19 668 1.1× 494 0.8× 467 1.3× 135 0.6× 148 0.9× 33 1.2k
Aaron J. Towers United States 10 328 0.5× 265 0.4× 516 1.5× 291 1.2× 102 0.6× 11 1.2k
Donna M. Werling United States 12 735 1.2× 978 1.6× 383 1.1× 112 0.5× 254 1.5× 18 1.6k
Hala Harony‐Nicolas United States 17 547 0.9× 572 0.9× 380 1.1× 347 1.5× 44 0.3× 29 1.2k
Charlotte Modahl United States 11 525 0.8× 880 1.4× 240 0.7× 668 2.8× 331 1.9× 12 1.6k
Claire S. Leblond France 14 475 0.8× 478 0.8× 352 1.0× 114 0.5× 47 0.3× 18 892
Dorina Winter Germany 19 390 0.6× 518 0.8× 281 0.8× 226 1.0× 538 3.1× 28 1.4k
Hewlet G. McFarlane United States 8 328 0.5× 483 0.8× 319 0.9× 264 1.1× 57 0.3× 13 1.1k

Countries citing papers authored by Danielle Halpern

Since Specialization
Citations

This map shows the geographic impact of Danielle Halpern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Halpern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Halpern more than expected).

Fields of papers citing papers by Danielle Halpern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Halpern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Halpern. The network helps show where Danielle Halpern may publish in the future.

Co-authorship network of co-authors of Danielle Halpern

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Halpern. A scholar is included among the top collaborators of Danielle Halpern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Halpern. Danielle Halpern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cáceres, Antonia San José, Emma Wilkinson, Daisy Crawley, et al.. (2024). Investigating social orienting in children with Phelan-McDermid syndrome and ‘idiopathic’ autism. Journal of Neurodevelopmental Disorders. 16(1). 64–64.
2.
Levy, Tess, Paige M. Siper, Danielle Halpern, et al.. (2024). Clinical, genetic, and cognitive correlates of seizure occurrences in Phelan-McDermid syndrome. Journal of Neurodevelopmental Disorders. 16(1). 25–25. 2 indexed citations
3.
Levy, Tess, Jessica Zweifach, Danielle Halpern, et al.. (2023). Prospective phenotyping of CHAMP1 disorder indicates that coding mutations may not act through haploinsufficiency. Human Genetics. 142(9). 1385–1394.
4.
Levy, Tess, Bari Britvan, Jordana Weissman, et al.. (2022). Assessing the utility of electronic measures as a proxy for cognitive ability. Autism Research. 15(6). 988–995.
5.
Levy, Tess, Paige M. Siper, Danielle Halpern, et al.. (2022). DDX3X Syndrome: Summary of Findings and Recommendations for Evaluation and Care. Pediatric Neurology. 138. 87–94. 17 indexed citations
6.
Guillory, Sylvia, Yian Zhang, Tess Levy, et al.. (2022). Neural Markers of Auditory Response and Habituation in Phelan-McDermid Syndrome. Frontiers in Neuroscience. 16. 815933–815933. 6 indexed citations
7.
Tang, Lara, Tess Levy, Sylvia Guillory, et al.. (2021). Prospective and detailed behavioral phenotyping in DDX3X syndrome. Molecular Autism. 12(1). 36–36. 29 indexed citations
8.
Guillory, Sylvia, Emma Wilkinson, Jordana Weissman, et al.. (2021). Social visual attentional engagement and memory in Phelan-McDermid syndrome and autism spectrum disorder: a pilot eye tracking study. Journal of Neurodevelopmental Disorders. 13(1). 58–58. 8 indexed citations
9.
Siper, Paige M., Sylvia Guillory, Teresa Tavassoli, et al.. (2021). Visual Evoked Potential Abnormalities in Phelan-McDermid Syndrome. Journal of the American Academy of Child & Adolescent Psychiatry. 61(4). 565–574.e1. 8 indexed citations
10.
Foss‐Feig, Jennifer H., Yitzchak Frank, Danielle Halpern, et al.. (2021). A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome. Molecular Autism. 12(1). 62–62. 12 indexed citations
11.
Soorya, Latha, Louis Fogg, Edith V. Ocampo, et al.. (2021). Neurocognitive Outcomes from Memantine: A Pilot, Double-Blind, Placebo-Controlled Trial in Children with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. 31(7). 475–484. 18 indexed citations
12.
Rubeis, Silvia De, Paige M. Siper, Allison Durkin, et al.. (2018). Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by SHANK3 point mutations. Molecular Autism. 9(1). 31–31. 138 indexed citations
13.
Tavassoli, Teresa, Paige M. Siper, A. Ting Wang, et al.. (2015). Measuring Sensory Reactivity in Autism Spectrum Disorder: Application and Simplification of a Clinician-Administered Sensory Observation Scale. Journal of Autism and Developmental Disorders. 46(1). 287–293. 52 indexed citations
14.
Tavassoli, Teresa, A lexander Kolevzon, A. Ting Wang, et al.. (2014). De novo SCN2A splice site mutation in a boy with Autism spectrum disorder. BMC Medical Genetics. 15(1). 35–35. 44 indexed citations
15.
Soorya, Latha, Paige M. Siper, Todd Beck, et al.. (2014). Randomized Comparative Trial of a Social Cognitive Skills Group for Children With Autism Spectrum Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 54(3). 208–216.e1. 55 indexed citations
16.
Kolevzon, A lexander, Lauren Bush, Andrew Wang, et al.. (2014). A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome. Molecular Autism. 5(1). 54–54. 93 indexed citations
17.
Grodberg, David, et al.. (2013). The Autism Mental Status Exam: Sensitivity and Specificity Using DSM-5 Criteria for Autism Spectrum Disorder in Verbally Fluent Adults. Journal of Autism and Developmental Disorders. 44(3). 609–614. 19 indexed citations
18.
Soorya, Latha, A lexander Kolevzon, Jessica Zweifach, et al.. (2013). Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency. Molecular Autism. 4(1). 18–18. 236 indexed citations
19.
Anagnostou, Evdokia, Latha Soorya, William F. Chaplin, et al.. (2012). Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial. Molecular Autism. 3(1). 16–16. 271 indexed citations
20.
Carpenter, Laura A., Latha Soorya, & Danielle Halpern. (2009). Asperger's Syndrome and High-Functioning Autism. Pediatric Annals. 38(1). 30–35. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Ting Wang Breakdown of academic impact, for papers by Meixiang Jia Breakdown of academic impact, for papers by Carolyn M. Yrigollen Breakdown of academic impact, for papers by Aaron J. Towers Breakdown of academic impact, for papers by Donna M. Werling Breakdown of academic impact, for papers by Hala Harony‐Nicolas Breakdown of academic impact, for papers by Charlotte Modahl Breakdown of academic impact, for papers by Claire S. Leblond Breakdown of academic impact, for papers by Dorina Winter Breakdown of academic impact, for papers by Hewlet G. McFarlane
Rankless by CCL
2026